Dow Up 0.12% Nasdaq Up 1.35%

Gilead Sciences Inc. (GILD)

-NasdaqGS
102.21 Up 1.46(1.45%) Oct 20, 4:00PM EDT
|After Hours : 102.69 Up 0.48 (0.47%) Oct 20, 7:59PM EDT
Prev Close:100.75
Open:101.15
Bid:102.13 x 100
Ask:N/A
1y Target Est:118.08
Beta:0.98
Next Earnings Date:28-Oct-14GILD Earnings announcement
Day's Range:100.82 - 103.59
52wk Range:63.50 - 110.64
Volume:11,892,203
Avg Vol (3m):14,444,200
Market Cap:154.51B
P/E (ttm):23.16
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GILD

Comparison

Symbol% ChgMkt Cap
GILDUp 1.45%154.51B
GSKDown 0.14%104.75B
PFEUp 0.36%177.10B
RHHBYUp 1.26%243.60B

Key Statistics

Forward P/E (1 yr):10.67
P/S (ttm):8.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.06
Quarterly EPS Est (Sep-14) :1.93
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback